Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 05 2021
Historique:
revised: 27 09 2020
received: 23 06 2020
accepted: 01 10 2020
pubmed: 27 10 2020
medline: 8 9 2021
entrez: 26 10 2020
Statut: ppublish

Résumé

A full-term pregnancy is associated with reduced endometrial cancer risk; however, whether the effect of additional pregnancies is independent of age at last pregnancy is unknown. The associations between other pregnancy-related factors and endometrial cancer risk are less clear. We pooled individual participant data from 11 cohort and 19 case-control studies participating in the Epidemiology of Endometrial Cancer Consortium (E2C2) including 16 986 women with endometrial cancer and 39 538 control women. We used one- and two-stage meta-analytic approaches to estimate pooled odds ratios (ORs) for the association between exposures and endometrial cancer risk. Ever having a full-term pregnancy was associated with a 41% reduction in risk of endometrial cancer compared to never having a full-term pregnancy (OR = 0.59, 95% confidence interval [CI] 0.56-0.63). The risk reduction appeared the greatest for the first full-term pregnancy (OR = 0.78, 95% CI 0.72-0.84), with a further ~15% reduction per pregnancy up to eight pregnancies (OR = 0.20, 95% CI 0.14-0.28) that was independent of age at last full-term pregnancy. Incomplete pregnancy was also associated with decreased endometrial cancer risk (7%-9% reduction per pregnancy). Twin births appeared to have the same effect as singleton pregnancies. Our pooled analysis shows that, while the magnitude of the risk reduction is greater for a full-term pregnancy than an incomplete pregnancy, each additional pregnancy is associated with further reduction in endometrial cancer risk, independent of age at last full-term pregnancy. These results suggest that the very high progesterone level in the last trimester of pregnancy is not the sole explanation for the protective effect of pregnancy.

Identifiants

pubmed: 33105052
doi: 10.1002/ijc.33360
pmc: PMC7969437
mid: NIHMS1671172
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2068-2078

Subventions

Organisme : U.S. Public Health Service
ID : R01-CA-55700
Organisme : NCI NIH HHS
ID : R03 CA096400
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA105212
Pays : United States
Organisme : NCI NIH HHS
ID : N01-CN-05223
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA169888
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA48774
Pays : United States
Organisme : NCI NIH HHS
ID : K05 CA092002
Pays : United States
Organisme : U.S. Public Health Service
ID : P01-CA-33619
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA118100
Pays : United States
Organisme : NCI NIH HHS
ID : N01-CN-55424
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA087538
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA39742
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164974
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA048737
Pays : United States
Organisme : NIH HHS
ID : R01 CA74877
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA182934
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA058598
Pays : United States
Organisme : NCI NIH HHS
ID : 2R01 CA082838
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA77398
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA118100
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA39779
Pays : United States
Organisme : U.S. Public Health Service
ID : R01-CA-58598
Organisme : NIEHS NIH HHS
ID : P30 ES000260
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA092585
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA082838
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA135632
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA058420
Pays : United States
Organisme : NCI NIH HHS
ID : CA11535
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA047749
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA039742
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA87969
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA083918
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA47749
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA033619
Pays : United States
Organisme : U.S. Public Health Service
ID : P20-CA-57113
Organisme : NCI NIH HHS
ID : R01 CA75977
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA077596
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA098346
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA077398
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA081212
Pays : United States
Organisme : CIHR
Pays : Canada
Organisme : NCI NIH HHS
ID : P01-CA77596
Pays : United States
Organisme : NICHD NIH HHS
ID : N01 HD023166
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA14089
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164973
Pays : United States

Informations de copyright

© 2020 UICC.

Références

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1296-301
pubmed: 15298949
Eur J Cancer Prev. 2002 Jun;11(3):283-93
pubmed: 12131662
Eur J Cancer. 2011 Mar;47(4):586-91
pubmed: 21055917
Int J Cancer. 2004 Feb 10;108(4):613-9
pubmed: 14696129
PLoS One. 2012;7(10):e46042
pubmed: 23056232
Am J Epidemiol. 2012 Aug 15;176(4):269-78
pubmed: 22831825
Am J Epidemiol. 2006 Oct 15;164(8):775-86
pubmed: 16997897
Am J Obstet Gynecol. 1991 Feb;164(2):522-7
pubmed: 1992695
Am J Obstet Gynecol. 1992 Nov;167(5):1317-25
pubmed: 1442985
Int J Cancer. 2019 Oct 1;145(7):1719-1730
pubmed: 30387875
BMJ. 2019 Aug 14;366:l4693
pubmed: 31412996
Int J Cancer. 1998 Jun 10;76(6):784-6
pubmed: 9626340
BMC Pregnancy Childbirth. 2018 Sep 5;18(1):360
pubmed: 30185145
Epidemiology. 2011 Sep;22(5):638-45
pubmed: 21691206
Br J Cancer. 1988 Feb;57(2):205-12
pubmed: 3358913
Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):23-9
pubmed: 10649152
J Clin Oncol. 2013 Jul 10;31(20):2607-18
pubmed: 23733771
Oncology. 1996 Sep-Oct;53(5):354-9
pubmed: 8784467
Cancer Causes Control. 1999 Feb;10(1):43-9
pubmed: 10334641
Obstet Gynecol. 2011 Nov;118(5):1029-1036
pubmed: 22015870
Int J Cancer. 2010 Jul 15;127(2):442-51
pubmed: 19924816
Acta Obstet Gynecol Scand. 2008;87(11):1123-8
pubmed: 18951203
Int J Cancer. 2002 Apr 20;98(6):912-5
pubmed: 11948472
BMC Pregnancy Childbirth. 2016 Jul 04;16(1):146
pubmed: 27377060
Endocr Rev. 2013 Feb;34(1):130-62
pubmed: 23303565
Cancer Causes Control. 1998 Dec;9(6):653-7
pubmed: 10189052
Am J Epidemiol. 1996 Jun 15;143(12):1195-202
pubmed: 8651218
Br J Cancer. 2007 May 7;96(9):1450-6
pubmed: 17426703
J Natl Cancer Inst. 1985 Apr;74(4):741-5
pubmed: 3857369
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Susan J Jordan (SJ)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Public Health, University of Queensland, Brisbane, Queensland, Australia.

Renhua Na (R)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Elisabete Weiderpass (E)

Director's Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.

Hans-Olov Adami (HO)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.

Kristin E Anderson (KE)

School of Public Health, Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, Minnesota, USA.
Screening, Prevention, Etiology and Cancer Survivorship Program, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA.

Piet A van den Brandt (PA)

Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Louise A Brinton (LA)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Chu Chen (C)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Linda S Cook (LS)

Division of Epidemiology, Biostatistics & Preventive Medicine, Department of Internal Medicine, NM Health Sciences Center, University of New Mexico, University of New Mexico, Albuquerque, New Mexico, USA.

Jennifer A Doherty (JA)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

Mengmeng Du (M)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Christine M Friedenreich (CM)

Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada.
Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Gretchen L Gierach (GL)

Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Marc T Goodman (MT)

Cancer Prevention and Control Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Vittorio Krogh (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Fabio Levi (F)

Department of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Lingeng Lu (L)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.

Anthony B Miller (AB)

Epidemiology Division, Dalla Lana School of Public Health, Toronto, Ontario, Canada.

Susan E McCann (SE)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

Kirsten B Moysich (KB)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

Eva Negri (E)

Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.

Sara H Olson (SH)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Stacey Petruzella (S)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Julie R Palmer (JR)

Slone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.

Fabio Parazzini (F)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Department of Obstetrics and Gynaecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Malcolm C Pike (MC)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Anna E Prizment (AE)

Screening, Prevention, Etiology and Cancer Survivorship Program, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA.
Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.

Timothy R Rebbeck (TR)

Division of Population Science, Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.

Peggy Reynolds (P)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

Fulvio Ricceri (F)

Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.

Harvey A Risch (HA)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.

Thomas E Rohan (TE)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Leo J Schouten (LJ)

Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Diego Serraino (D)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.

Veronica W Setiawan (VW)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Xiao-Ou Shu (XO)

Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Todd R Sponholtz (TR)

Slone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.

Amanda B Spurdle (AB)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Rachael Z Stolzenberg-Solomon (RZ)

Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Britton Trabert (B)

Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Nicolas Wentzensen (N)

Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Bethesda, Maryland, USA.

Lynne R Wilkens (LR)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.

Lauren A Wise (LA)

Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.

Herbert Yu (H)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

Immaculata De Vivo (I)

Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

Wanghong Xu (W)

Department of Epidemiology, Fudan University School of Public Health, Shanghai, China.

Anne Zeleniuch-Jacquotte (A)

Department of Population Health and Perlmutter Cancer Center, New York University Langone Health, New York, New York, USA.

Penelope M Webb (PM)

Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Public Health, University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH